FDA Label for Circulopath

View Indications, Usage & Precautions

Circulopath Product Label

The following document was submitted to the FDA by the labeler of this product Energetix Corp. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Active Ingredients:



Adenosinum cyclophosphoricum 10X; Arnica montana 30X; Aurum muriaticum 12X; Baryta muriatica 12X; Borago officinalis 4X; Cholesterinum 12X; Citrus limonum 4X; Hypothalamus (Bovine) 12X; Kali iodatum 12X; Laurocerasus 10X, 12X, 6C; Magnesia muriatica 8X, Nadidum 9X, 12X, 6C; Phaseolus 5X; Phosphorus 30X; Thyroidinum (Bovine) 12X.


Purpose:



Cold extremities, fatigue, pulsating headache, swollen veins.


Warnings:



In case of overdose, get medical help or contact a Poison Control Center right away.
If pregnant or breast feeding, ask a health professional before use.
Keep out of reach of children.


Other information
Store in a cool, dry place out of direct sunlight.
Do not use if neck wrap is broken or missing.


Keep Out Of Reach Of Children:



Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.


Directions:



Take 30 drops orally twice daily or as directed by a healthcare professional.
Consult a physician for use in children under 12 years of age.


Uses:



Temporary relief of cold extremities, fatigue, pulsating headache, swollen veins.


Inactive Ingredients:



Purified Water, Glycerin 15%, Ethanol 15%.


Questions:



Distributed by
Energetix Corp.
Dahlonega, GA 30533


Questions? 800.990.7085
www.goenergetix.com


Package Label Display:



energetix
Circulopath
Homeopathic Remedy


Cold extremities, fatigue, pulsating headache,

swollen veins.

2 fl oz (59.1 mL)


* Please review the disclaimer below.